Table 2. Positive correlation between CT, HPV, and cervical cancer.
CT: Chlamydia trachomatis; HPV: human papillomavirus; HrHPV: high-risk human papillomavirus; LSIL: low-grade squamous intraepithelial lesion; CC: cervical cancer
Author | Year of publication | Study design | Population characteristics | Sample size | Outcome |
Chen et al. [8] | 2020 | Cross-sectional study | Gynecology clinic in southern Hunan, China | 5,006 | CT infection was associated with HrHPV infection with an odds ratio of 1.74 (95% CI: 1.10–2.74, p=0.017) |
Ssedyabane et al. [4] | 2019 | Cross-sectional study | Age: 25-80 years; hospital in southwestern Uganda | 93 | There is a likelihood of association between HPV-CT coinfection and the cytological diagnosis of LSIL (Spearman's rho=0.2784, prob >|t|=0.0069) |
Madaan et al. [7] | 2019 | Cross-sectional study | Age: 18-45 years; STI clinic in New Delhi, India | 90 | A highly significant association was found between HPV-CT coinfection and cervical abnormal cytology (p=0.001) |
Lv et al. [24] | 2019 | Cross-sectional study | Age: 20-70 years; outpatient clinic in Shanghai, China | 826 | Data evaluated showed that CT (OR: 3.538) is a risk factor for hrHPV infection (p<0.05) |
Mancini et al. [25] | 2018 | Cohort study | Multicenter, Italy | 164 | A high percentage (15/16; 94%) of CT-HPV coinfections have high-grade cervical lesions more frequently than those infected with HPV only |
Zhu et al. [6] | 2016 | Meta-analysis | 22 studies | 4,291 | CT was significantly linked to increased CC risk in prospective studies (OR: 2.21, 95% CI: 1.88-2.61) |
Arnheim Dahlström et al. [26] | 2011 | Prospective cohort study | 4 major biobanks in Nordic countries | 1,000,000 | Previous exposure to CT; had a strongly increased risk for CC (OR: 1.9; 95% CI: 1.5-2.3) |